1. Home
  2. FLGT vs CIM Comparison

FLGT vs CIM Comparison

Compare FLGT & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$28.05

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Logo Chimera Investment Corporation

CIM

Chimera Investment Corporation

HOLD

Current Price

$13.08

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
CIM
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
867.4M
1.0B
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
FLGT
CIM
Price
$28.05
$13.08
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$28.33
$15.25
AVG Volume (30 Days)
205.0K
858.8K
Earning Date
02-27-2026
02-11-2026
Dividend Yield
N/A
11.35%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$315,549,000.00
$191,573,000.00
Revenue This Year
$16.84
$11.44
Revenue Next Year
$9.74
$21.50
P/E Ratio
N/A
N/A
Revenue Growth
13.61
N/A
52 Week Low
$14.57
$9.85
52 Week High
$31.04
$15.37

Technical Indicators

Market Signals
Indicator
FLGT
CIM
Relative Strength Index (RSI) 55.75 57.53
Support Level $27.56 $12.27
Resistance Level $28.44 $13.19
Average True Range (ATR) 0.71 0.27
MACD 0.18 0.04
Stochastic Oscillator 82.51 88.24

Price Performance

Historical Comparison
FLGT
CIM

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: